(Q42243408)

English

Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine

scientific article published on December 15, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine (English)

1 reference

Europe PubMed Central

19 October 2017

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

author name string

M. Slavik

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

K. J. Smith

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

O. Blanc

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

language of work or name

0 references

publication date

1 December 1982

1 reference

Europe PubMed Central

19 October 2017

15 December 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6186258

23 August 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0006295282906645?httpAccept=text/xml

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

https://api.elsevier.com/content/article/PII:0006295282906645?httpAccept=text/plain

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Biochemical Pharmacology

1 reference

Europe PubMed Central

19 October 2017

31

1 reference

Europe PubMed Central

19 October 2017

24

1 reference

Europe PubMed Central

19 October 2017

4089-4092

1 reference

Europe PubMed Central

19 October 2017

Typical hyperaminoaciduria after high doses of 6-azauridine triacetate

3

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

‘Homocystinuria’ and urinary excretion of β-amino acids in patients treated with 6-azauridine

4

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate

7

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Cancer Treatment Reports

8

63

1041

author name string

Slavik

publication date

1979

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Effect of 6-azauracil, and of certain structurally similar compounds, on three pyridoxal-phosphate requiring enzymes involved in neurotransmitter metabolism

9

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

A simple enzymic assay for pyridoxal phosphate

11

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis Fungoides

16

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Treatment of mycosis fungoides with 6-azauracilriboside

17

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Calabresi P: Treatment of polycythemia vera with azauridine and azaribine

19

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

6-azauridine-induced changes of the trophoblast in early human pregnancy

20

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Letter: Thrombosis and psoriasis

22

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Nucleoside analogs in the treatment of nonneoplastic diseases

25

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Identifiers

10.1016/0006-2952(82)90664-5

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42243408&oldid=1959686089"